考比替尼是一种激酶抑制剂,其适应症为: • 与维莫非尼联合用于治疗携带 BRAF V600E 或 V600K 突变的不可切除或转移性黑色素瘤成年患者。 • 作为单药用于治疗组织细胞肿瘤成年患者。
相关产品
¥19.68
≈ ₭61,000
≈ ₭61,000
0 out of 5
¥639.52
≈ ₭1,982,500
≈ ₭1,982,500
0 out of 5
¥1,328.23
≈ ₭4,117,500
≈ ₭4,117,500
0 out of 5
¥2,015.00
≈ ₭6,246,500
≈ ₭6,246,500
0 out of 5
¥2,115.32
≈ ₭6,557,500
≈ ₭6,557,500
0 out of 5
¥196.77
≈ ¥196.77
≈ ₭610,000 – ₭1,830,000价格范围:₭610,000 至 ₭1,830,000
≈ ¥196.77
≈ ₭610,000 – ₭1,830,000价格范围:₭610,000 至 ₭1,830,000
0 out of 5
BRAF V600E靶点
¥1,967.74
≈ ₭6,100,000
≈ ₭6,100,000
0 out of 5
¥515.00
≈ ₭1,596,500
≈ ₭1,596,500
0 out of 5














评价
目前还没有评价